Some of the prevailing trends in healthcare and biotech funds during Covid-19 pandemic will reverse as the economy opens up post-pandemic, says Angelica Fatouros, portfolio manager of healthcare and biotechnology funds at SEB Investment Management.
In general, healthcare sector has been less impacted by the pandemic than many other businesses, Fatouros tells AMWatch in a written comment.
More from AMWatch
95 percent of active global high-yield managers struggle to consistently add value net of fees, according to the world's fourth-largest asset manager ahead of launching a global HY index fund. However, a recent survey by consultancy Kirstein showed a vast majority of Nordic investors preferring their HY portfolios actively managed.